ProxyMiner / Company

BECTON DICKINSON & COBDX

Latest proxy: 2025 · view on SEC ↗ · CIK 0000010795

CEO total pay

$17,129,140

Thomas E. Polen · 2025

Say on pay

Not disclosed

Use Ask for the underlying narrative

CEO pay ratio

CD&A

374 to 1

Item 402(u) section may live outside the CD&A

Compensation committee

CD&A

Compensation Committee

Per the latest proxy

Filings indexed: 2 · 2025 · 2024

Executive pay

What did they pay them?

From the Summary Compensation Table. Pay mix and YoY are computed from these rows.

ExecutiveRoleTotalYoYPay mixSalaryStockCash incentiveOther
Thomas E. Polen2025 compensation
Chairman, Chief Executive Officerand President
$17,129,140 1%
87% at-risk
$1,395,463$9,991,854$1,852,010$341,251
Christopher J. DelOrefice2025 compensation
Executive Vice President andChief Financial Officer
$5,877,164 4%
80% at-risk
$837,500$3,140,481$722,500$135,767
Michael C. Feld2025 compensation
Executive Vice President, ChiefRevenue Officer and President,Life Sciences Segment
$4,096,356
61% at-risk
$775,000$1,641,596$533,588$602,054
Michael D. Garrison2025 compensation
Executive Vice Presidentand President, MedicalEssentials and BioPharmaSystems Segments
$3,649,040 1%
72% at-risk
$768,750$1,641,596$533,588$58,188
Richard E. Byrd2025 compensation
Executive Vice President and President, InterventionalSegment
$3,399,056 4%
71% at-risk
$756,250$1,427,531$592,875$57,429

Pay mix: base cash incentive equity other

CD&A excerpt

Compensation discussion & analysis

Opening passage of the loaded filing's CD&A. Use Ask below to query the full text with citations.

Executive summary This section provides an overview of our executive compensation philosophy and executive compensation program, and the compensation actions taken with respect to our named executive officers. The named executive officers for fiscal year 2025 were: •Thomas E. Polen, Chairman, Chief Executive Officer and President •Christopher J. DelOrefice, Executive Vice President and Chief Financial Officer •Richard E. Byrd, Executive Vice President and President, Interventional Segment •Michael C. Feld, Executive Vice President, Chief Revenue Officer and President, Life Sciences Segment •Michael D. Garrison, Executive Vice President and President, Medical Essentials and BioPharma Systems Segments On October 15, 2025, Mr. Feld's role was expanded to include the added title of Chief Revenue Officer. He will remain Executive Vice President and President, Life Sciences Segment until the closing of the RMT transaction with Waters Corporation (“Waters”) to combine the BD Biosciences and Diagnostic Solutions business with Waters (the “Waters RMT Transaction”). In addition, on October 15, 2025, we disclosed that Mr. DelOrefice notified us of his resignation in order to pursue a new prof

Read the full CD&A on SEC.gov ↗

Peer comparison

Who they benchmark against

Click any peer to jump to their proxy. Peers we haven't ingested yet kick off an import on click.

Governance

Policy guardrails

  • hedging

    prohibited

    Prohibition on pledging BD shares or hedging against the economic risk of ownership

  • pledging

    prohibited

    Prohibition on pledging BD shares or hedging against the economic risk of ownership

  • clawback

    present

    clawback policy” applies to all compensation under the PIP and LTI plans for the broader group of senior managers, including time-based and performance-based compensation

  • change in control

    Change in control

    Change in control

  • compensation committee

    Compensation Committee

    For the framework, the Compensation Committee asked questions such as

Performance markers

Metric facts

  • revenue

    $21.8 billion

    of unlocking significant value for shareholders and positioning the Company for sustainable growth.•New BD has a deep innovation pipeline in attractive markets such as Biologic Drug Delivery, Advanced Patient Monitoring,

  • operating income

    EPS is consistent with how we report our operating results to the financial community.Operating Margin PercentageOperating Margin Percentage focuses management on driving profitable, margin-accretive revenue growth. Incr

  • ceo pay ratio

    374 to 1

    of all our other worldwide employees. For fiscal year 2025, the median annual total compensation of all our employees (other than Mr. Polen) was $45,831 and Mr. Polen’s annual total compensation (as reported in the Summa

  • median employee compensation

    was performed for all employees, excluding Mr. Polen, whether employed on a full-time, part-time or seasonal basis. For seasonal and non-permanent employees, we applied a reasonable estimate of hourly rate multiplied by

Ask

Anything about BECTON DICKINSON & CO’s 2025 proxy

Answers are grounded in the loaded filing and cite specific artifacts. Bring your own free Google AI Studio key.

Loading the Ask interface…